Donald Jackson
About Donald Jackson
Donald Jackson is the Director of Translational Bioinformatics Cambridge at Bristol-Myers Squibb, specializing in oncology and immuno-oncology research.
Company
Donald Jackson is currently employed by Bristol-Myers Squibb, a well-known biopharmaceutical company. He operates at their Cambridge site in New Jersey, United States. In his role, he occupies several key positions, including Director of Translational Bioinformatics Cambridge, Research Fellow in Translational Bioinformatics, and Principal Scientist.
Title
Donald Jackson holds the title of Director of Translational Bioinformatics Cambridge at Bristol-Myers Squibb. His role involves leading a team focused on the identification of targets and therapies for cancers resistant to existing treatments.
Education and Expertise
Donald Jackson achieved his Doctor of Philosophy in Molecular Biology and Biochemistry from The Johns Hopkins University School of Medicine, completing his studies from 1990 to 1997. His professional expertise includes target discovery, target validation, and biomarker discovery, with a specific focus on oncology and immuno-oncology.
Background
Prior to his current roles, Donald Jackson has an extensive research background. He worked as a Postdoctoral Fellow at Massachusetts General Hospital from 1997 to 1999 in Boston, Massachusetts. Before that, he served as a Research Technician at Johns Hopkins School of Medicine from 1988 to 1990.
Achievements
Joining Bristol-Myers Squibb in November 2018, Donald Jackson leads a team dedicated to finding new targets and therapies for cancer treatment, particularly for cases resistant to existing treatments. His contributions extend to expertise in target discovery, validation, and biomarker discovery, significantly advancing the field of oncology and immuno-oncology.